Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krmpotic

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Plos Pathogens|February 7, 2015
Non-redundant and redundant roles of cytomegalovirus gH/gL complexes in host organ entry and intra-tissue spreadNiels A W Lemmermann, Astrid Krmpotic, Jürgen Podlech, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trialJ Jassem, T Pieńkowski, A Płuzańska, et al.
The Journal of General Virology|November 21, 2022
Two murine cytomegalovirus microRNAs target the major viral immediate early 3 geneStefanie Herb, Jelena Zeleznjak, Thomas Hennig, et al.
Zoology (Jena, Germany)|April 14, 2019
Adaptations to a semiaquatic lifestyle in the external ear of southern pinnipeds (Otariidae and Phocidae, Carnivora): Morphological evidencesCleopatra M Loza, Cecilia M Krmpotic, Fernando C Galliari, et al.
Plos Pathogens|October 27, 2010
Cytomegalovirus microRNAs facilitate persistent virus infection in salivary glandsLars Dölken, Astrid Krmpotic, Sheila Kothe, et al.
Plos Pathogens|April 28, 2017
IL-33/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infectionBranka Popovic, Mijo Golemac, Jürgen Podlech, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2013
FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG studyT Brodowicz, T E Ciuleanu, D Radosavljevic, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 7, 2012
CMV late phase-induced mTOR activation is essential for efficient virus replication in polarized human macrophagesM Poglitsch, T Weichhart, M Hecking, et al.
The Journal of Experimental Medicine|March 4, 2009
Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral responseAgnieszka Kielczewska, Michal Pyzik, Tianhe Sun, et al.
Plos Pathogens|September 17, 2019
Mucosal CD8+ T cell responses induced by an MCMV based vaccine vector confer protection against influenza challengeXiaoyan Zheng, Jennifer D Oduro, Julia D Boehme, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Plos Pathogens|February 7, 2015
Non-redundant and redundant roles of cytomegalovirus gH/gL complexes in host organ entry and intra-tissue spreadNiels A W Lemmermann, Astrid Krmpotic, Jürgen Podlech, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trialJ Jassem, T Pieńkowski, A Płuzańska, et al.
The Journal of General Virology|November 21, 2022
Two murine cytomegalovirus microRNAs target the major viral immediate early 3 geneStefanie Herb, Jelena Zeleznjak, Thomas Hennig, et al.
Zoology (Jena, Germany)|April 14, 2019
Adaptations to a semiaquatic lifestyle in the external ear of southern pinnipeds (Otariidae and Phocidae, Carnivora): Morphological evidencesCleopatra M Loza, Cecilia M Krmpotic, Fernando C Galliari, et al.
Plos Pathogens|October 27, 2010
Cytomegalovirus microRNAs facilitate persistent virus infection in salivary glandsLars Dölken, Astrid Krmpotic, Sheila Kothe, et al.
Plos Pathogens|April 28, 2017
IL-33/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infectionBranka Popovic, Mijo Golemac, Jürgen Podlech, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2013
FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG studyT Brodowicz, T E Ciuleanu, D Radosavljevic, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 7, 2012
CMV late phase-induced mTOR activation is essential for efficient virus replication in polarized human macrophagesM Poglitsch, T Weichhart, M Hecking, et al.
The Journal of Experimental Medicine|March 4, 2009
Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral responseAgnieszka Kielczewska, Michal Pyzik, Tianhe Sun, et al.
Plos Pathogens|September 17, 2019
Mucosal CD8+ T cell responses induced by an MCMV based vaccine vector confer protection against influenza challengeXiaoyan Zheng, Jennifer D Oduro, Julia D Boehme, et al.
Pageof 8